Drug Approval | October 14, 2025
Biocon gets 1 USFDA observation for Cranbury site
The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
The facility has been classified as Voluntary Action Indicated
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Delegates also visited Emami’s WHO-GMP-certified manufacturing plant and Zandu Foundation for Healthcare farms for hands-on exposure to quality practices,
_256_384.jpg)
Marksans Pharma gets USFDA nod for acid reflux drug
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
Subscribe To Our Newsletter & Stay Updated
